PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT PHIO PHARMACEUTICALS CORP.Phio Pharmaceuticals Corp. • November 20th, 2019 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [________________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on November 18, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Phio Pharmaceuticals Corp., a Delaware corporation (the “Company”), up to [_______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Placement Agency Agreement, dated as of November 18, 2019, by and between the Company and H.C. Wainwright & Co., LLC (the “Placement
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 20th, 2019 • Phio Pharmaceuticals Corp. • Pharmaceutical preparations • New York
